EGFR and lung cancer: With a better understanding of the biology of lung cancer in recent years, several groups have proposed novel strategies targeting the epidermal growth factor receptor (EGFR), other receptor and non-receptor tyrosine kinases, and vascular endothelial growth factor (VEGF) pathways [3].